See also this year's filing and all EDGAR filings for this company.
PDF Report 0001430306_2022_Tonix_Pharmaceuticals_Holding_Corp.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001430306')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001430306, Tonix Pharmaceuticals Holding Corp.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 189,049,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 120,000 |
| 2 | PropertyPlantAndEquipmentNet | 50,558,000 |
| 3 | remainder_Assets | 1,173,000 |
| 4 | LiabilitiesCurrent | 21,716,000 |
| 5 | LiabilitiesNoncurrent | 467,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 23,474,000 |
| 9 | ResearchAndDevelopmentExpense | 68,838,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 25,000 |
| 13 | remainder_ComprehensiveNetIncome | -30,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 240,900,000 |
| 1 | Liabilities | 22,183,000 |
| 2 | Expenses | 92,312,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 218,717,000 |
| 5 | NetIncome | -92,287,000 |
| 6 | ComprehensiveNetIncome | -92,302,000 |
| 7 | BaseVar | 177,725,000 |
| 8 | EconomicCapitalRatio | 2.16 |
Edgar->Model Mapping
Feature Distribution
Change over Time
